Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Oral Oncology Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553667842375680 |
|---|---|
| author | B. Haridevamuthu Gokul Sudhakaran Sathishkumar Kuppusamy Meivelu Moovendhan Ramadurai Murugan |
| author_facet | B. Haridevamuthu Gokul Sudhakaran Sathishkumar Kuppusamy Meivelu Moovendhan Ramadurai Murugan |
| author_sort | B. Haridevamuthu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-5196aafc7a9a415a8238571335e20f09 |
| institution | Kabale University |
| issn | 2772-9060 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Oral Oncology Reports |
| spelling | doaj-art-5196aafc7a9a415a8238571335e20f092025-01-09T06:16:26ZengElsevierOral Oncology Reports2772-90602024-06-0110100473Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trialsB. Haridevamuthu0Gokul Sudhakaran1Sathishkumar Kuppusamy2Meivelu Moovendhan3Ramadurai Murugan4Corresponding author.; Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, IndiaCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, IndiaCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, IndiaCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, IndiaCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, Indiahttp://www.sciencedirect.com/science/article/pii/S2772906024003194 |
| spellingShingle | B. Haridevamuthu Gokul Sudhakaran Sathishkumar Kuppusamy Meivelu Moovendhan Ramadurai Murugan Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials Oral Oncology Reports |
| title | Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials |
| title_full | Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials |
| title_fullStr | Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials |
| title_full_unstemmed | Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials |
| title_short | Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials |
| title_sort | advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma the imperative for rigorous clinical trials |
| url | http://www.sciencedirect.com/science/article/pii/S2772906024003194 |
| work_keys_str_mv | AT bharidevamuthu advancingimmunotherapyinrecurrentormetastaticheadandneckcutaneoussquamouscellcarcinomatheimperativeforrigorousclinicaltrials AT gokulsudhakaran advancingimmunotherapyinrecurrentormetastaticheadandneckcutaneoussquamouscellcarcinomatheimperativeforrigorousclinicaltrials AT sathishkumarkuppusamy advancingimmunotherapyinrecurrentormetastaticheadandneckcutaneoussquamouscellcarcinomatheimperativeforrigorousclinicaltrials AT meivelumoovendhan advancingimmunotherapyinrecurrentormetastaticheadandneckcutaneoussquamouscellcarcinomatheimperativeforrigorousclinicaltrials AT ramaduraimurugan advancingimmunotherapyinrecurrentormetastaticheadandneckcutaneoussquamouscellcarcinomatheimperativeforrigorousclinicaltrials |